Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to -48 cents per share on August 10

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q2'26

Est.

$-0.48

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.19

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.18

The last earnings report on April 30 showed earnings per share of -47 cents, beating the estimate of -62 cents. With 71.23K shares outstanding, the current market capitalization sits at 1.71B.

View a ticker or compare two or three

Compare

SNDX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SNDX